Weekly Cisplatin plus Capecitabine is an active regimen in heavily pretreated advanced breast cancer patients

被引：0
|
作者：
Donadio, Michela [1 ]
Beano, Alessandra [1 ]
Ardine, Mara [1 ]
Bonardi, Simone [2 ]
Mistrangelo, Marinella [1 ]
Polimeni, Maria A. [1 ]
Castiglione, Federico [3 ]
Forti, Laura [4 ]
Bottini, Alberto [2 ]
Bertetto, Oscar [1 ]
机构：
[1] Azienda Osped San Giovanni Battista, COES, Turin, Italy
[2] Azienda Osped Ist Ospetalieri, Cremona, Italy
[3] Osped San Lazzaro, Alba, Italy
[4] Osped Maggiore La Carita, SCDU Oncol Med, Novara, Italy
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：46 / 46
页数：1
相关论文
共 50 条
  • [31] Symptom improvement with pemetrexed for heavily pretreated patients with advanced breast cancer.
    O'Shaughnessy, J
    Liepa, AM
    Nguyen, B
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S133 - S133
  • [32] A phase II study of capecitabine plus cisplatin in metastatic triple-negative breast cancer patients pretreated with anthracyclines and taxanes
    Li, Qiao
    Li, Qing
    Zhang, Pin
    Yuan, Peng
    Wang, Jiayu
    Ma, Fei
    Luo, Yang
    Fan, Ying
    Cai, Ruigang
    Xu, Binghe
    CANCER BIOLOGY & THERAPY, 2015, 16 (12) : 1746 - 1753
  • [33] A phase II study of capecitabine plus cisplatin in metastatic triple-negative breast cancer patients pretreated with anthracyclines and taxanes
    Li, Qiao
    Xu, Binghe
    Li, Qing
    Zhang, Pin
    Yuan, Peng
    Wang, Jiayu
    Ma, Fei
    Luo, Yang
    Fan, Ying
    Cai, Ruigang
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [34] Phase I study of weekly docetaxel (Taxotere(R)) in heavily pretreated breast cancer patients
    Luck, HJ
    Donne, S
    Glaubitz, M
    Kuhnle, H
    Marhenke, P
    Welker, T
    Dreps, A
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 703 - 703
  • [35] Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer
    Stemmler, H. J.
    diGioia, D.
    Freier, W.
    Tessen, H. W.
    Gitsch, G.
    Jonat, W.
    Brugger, W.
    Kettner, E.
    Abenhardt, W.
    Tesch, H.
    Hurtz, H. J.
    Roesel, S.
    Brudler, O.
    Heinemann, V.
    BRITISH JOURNAL OF CANCER, 2011, 104 (07) : 1071 - 1078
  • [36] Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer
    H J Stemmler
    D diGioia
    W Freier
    H W Tessen
    G Gitsch
    W Jonat
    W Brugger
    E Kettner
    W Abenhardt
    H Tesch
    H J Hurtz
    S Rösel
    O Brudler
    V Heinemann
    British Journal of Cancer, 2011, 104 : 1071 - 1078
  • [37] A retrospective comparison of S-1 plus cisplatin and capecitabine plus cisplatin for patients with advanced or recurrent gastric cancer
    Shitara, Kohei
    Sawaki, Akira
    Matsuo, Keitaro
    Kondo, Chihiro
    Takahari, Daisuke
    Ura, Takashi
    Tajika, Masahiro
    Niwa, Yasumasa
    Muro, Kei
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2013, 18 (03) : 539 - 546
  • [38] Oral vinorelbine plus capecitabine combination in patients with advanced breast cancer
    Sambiasi, D.
    Spada, M.
    Giampaglia, M.
    Misino, A.
    Calabrese, R.
    Latorre, A.
    Lorusso, V.
    ANNALS OF ONCOLOGY, 2005, 16 : 145 - 145
  • [39] A retrospective comparison of S-1 plus cisplatin and capecitabine plus cisplatin for patients with advanced or recurrent gastric cancer
    Kohei Shitara
    Akira Sawaki
    Keitaro Matsuo
    Chihiro Kondo
    Daisuke Takahari
    Takashi Ura
    Masahiro Tajika
    Yasumasa Niwa
    Kei Muro
    International Journal of Clinical Oncology, 2013, 18 : 539 - 546
  • [40] ADHERENCE TO AND PERSISTENCE WITH AN ORAL METRONOMIC CHEMOTHERAPY WITH CAPECITABINE IN HEAVILY PRETREATED METASTATIC BREAST CANCER (MBC) PATIENTS
    Fedele, P.
    Nacci, A.
    Orlando, L.
    Marino, A.
    Cinefra, M.
    Cinieri, S.
    ANNALS OF ONCOLOGY, 2010, 21 : 120 - 121
12345